Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms, Squamous Cell 1Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Anus Neoplasms 1Anus Diseases 1Anal Canal Carcinoma 1

Interventions

Paclitaxel 11Fluorouracil 10pembrolizumab 9Cisplatin 9Radiotherapy 7Carboplatin 6Esophagectomy 5Nivolumab 4Drug Therapy 4Radiotherapy, Intensity-Modulated 3Leucovorin 3Chemoradiotherapy 3Cetuximab 3Capecitabine 3durvalumab 2atezolizumab 2Oxaliplatin 2Ipilimumab 2spartalizumab 1sintilimab 1selinexor 1regorafenib 1prexasertib 1osimertinib 1niraparib 1nilotinib 1nedaplatin 1nanocis 1fludarabine 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Mitomycins × Gastrointestinal × Clear all
NCT02526953 2021-02-09

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

Blokhin's Russian Cancer Research Center

Phase 3 Unknown
314 enrolled
Gastrointestinal

Anus Diseases, Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡